【HONGSENG 0041 交流专区】（前名 MYSCM）

icy97

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) RELATED PARTY TRANSACTIONS
Description	HONG SENG CONSOLIDATED BERHAD (FORMELY KNOWN AS MSCM HOLDINGS BERHAD) ("HONG SENG" OR "COMPANY") AND ITS SUBSIDIARIES ("HONG SENG GROUP" OR THE "GROUP")PROPOSED ACQUISITION OF 1,029,000 ORDINARY SHARES REPRESENTING 49% OF THE ENTIRE EQUITY INTEREST IN HS BIO SUPPLIES SDN. BHD. (FORMERLY KNOWN AS HC MSC SDN BHD) FROM UNITED ICT CONSORTIUM SDN. BHD.
The Board of Directors of Hong Seng (“Board” or “the Company” or “the Purchaser”) wishes to announce that the Company had on 12 October 2020 entered into a Share Sale Agreement with United ICT Consortium Sdn. Bhd. (Registration No.: 201101010217 (938356-T)), a wholly-owned subsidiary of MMAG Holdings Berhad (Registration No.: 200301007003 (609423-V)) for the proposed acquisition of 49% of the entire equity interest in HS Bio Supplies Sdn Bhd (formerly known as HC MSC Sdn Bhd) (Registration No.: 200001004517 (507122-D)), comprising 1,029,000 ordinary shares for a cash consideration of RM980,001.00 only. Details of the announcement are set out in the file attached. This announcement is dated 12 October 2020.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3095438

Attachments Hong Seng - Announcement for Acquisition of shares in HS Bio-Final.pdf

icy97

HONG SENG CONSOLIDATED BERHAD

Date of change	19 Oct 2020
Name	MISS TEOH SOON HAN
Age	35
Gender	Female
Nationality	Malaysia
Designation	Executive Director
Directorate	Executive
Type of change	Resignation
Reason	to put more concentration on her personal career.
Details of any disagreement that he/she has with the Board of Directors	No
Whether there are any matters that need to be brought to the attention of shareholders	No

Qualifications

No

Qualifications

Major/Field of Study

Institute/University

Additional Information

Working experience and occupation	not applicable
Family relationship with any director and/or major shareholder of the listed issuer	Teoh Soon Han is the daughter Dato' Teoh Hai Hin, the Executive Chairman and major shareholder of Hong Seng Consolidated Berhad (formerly known as MSCM Holdings Berhad).

icy97

Type	Announcement
Subject	MULTIPLE PROPOSALS
Description	HONG SENG CONSOLIDATED BERHAD (FORMERLY KNOWN AS MSCM HOLDINGS BERHAD) ("HONG SENG" OR THE "COMPANY")(I)        PROPOSED DIVERSIFICATION INTO MANUFACTURING AND TRADING OF GLOVES AND OTHER PPE;(II)        PROPOSED DIVERSIFICATION INTO HEALTHCARE RELATED BUSINESS; (III)        PROPOSED DIVERSIFICATION INTO HIRE PURCHASE BUSINESS; AND(IV)        PROPOSED VARIATION(COLLECTIVELY REFERRED TO AS THE "PROPOSALS")
On behalf of the Board of Directors of Hong Seng, TA Securities Holdings Berhad wishes to announce that the Company proposes to undertake the following: (i) proposed diversification of the existing business of Hong Seng and its subsidiaries (“Hong Seng Group”) to include manufacturing and trading of gloves and other personal protective equipment (“PPE”) products and related business (“Proposed Diversification into Manufacturing and Trading of Gloves and Other PPE”); (ii) proposed diversification of the existing business of Hong Seng Group to include the supply of healthcare products and services and related business (“Proposed Diversification into Healthcare Related Business”); (iii) proposed diversification of the existing business of Hong Seng Group to include hire purchase and related business (“Proposed Diversification into Hire Purchase Business”); and (iv) proposed variation to the utilisation of proceeds raised from the rights issue of shares with warrants and rights issue of irredeemable convertible preference shares undertaken by Hong Seng (“Proposed Variation”). Please refer to the attachment for further details of the Proposals. This announcement is dated 19 October 2020.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3097555

Attachments Announcement.pdf

icy97

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	HONG SENG CONSOLIDATED BERHAD (FORMELY KNOWN AS MSCM HOLDINGS BERHAD) ("HONG SENG" OR "COMPANY") AND ITS SUBSIDIARIES ("HONG SENG GROUP" OR "THE GROUP")ACQUISITION OF 51,000 ORDINARY SHARES REPRESENTING 51% OF THE ENTIRE EQUITY INTEREST IN PANTASNIAGA SDN BHD BY HS BIO SUPPLIES SDN BHD (FORMERLY KNOWN AS HC MSC SDN BHD), A WHOLLY-OWNED SUBSIDIARY OF THE COMPANY
The Board of Directors of Hong Seng wishes to announce that HS Bio Supplies Sdn Bhd (formerly known as HC MSC Sdn Bhd), a wholly-owned subsidiary of the Company, had on 20 October 2020 entered into a Shares Sale Agreement with Norashikin Binti Tajuddin and Lee Yeow Tuck for the acquisition of 51% of the equity interest in Pantasniaga Sdn Bhd (Registration No.: 201301010688 (1040530-T)) (“Pantasniaga”), comprising 51,000 ordinary shares in Pantasniaga for a cash consideration of RM51.00 only. Details of the announcement are set out in the file attached. This announcement is dated 20 October 2020.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3097914

Attachments Hong Seng - Announcement for Acquisition of Subsidiary (Pantasniaga).pdf

icy97

Type	Announcement
Subject	OTHERS
Description	HONG SENG CONSOLIDATED BERHAD (FORMELY KNOWN AS MSCM HOLDINGS BERHAD) ("HONG SENG" OR THE "COMPANY") AND ITS SUBSIDIARIES ("HONG SENG GROUP")INCORPORATION OF NEW SUBSIDIARY
The Board of Directors of Hong Seng wishes to announce that the Company had on today received the notification from Companies Commission of Malaysia for the approval on the incorporation of a new wholly-owned subsidiary, namely HS Petchem Logistics Sdn Bhd (“HS Petchem”). HS Petchem is incorporated in Malaysia on 22 October 2020 under the Companies Act, 2016 with an issued share capital of RM100 divided into 100 ordinary shares and it is 100% owned by Hong Seng. The Directors of HS Petchem are Dato’ Teoh Hai Hin and Kenny Khow Chuan Wah. HS Petchem is incorporated for the purpose of involvement in petrochemical business to construct and operate tank farm facilities for feedstocks storage such as Butadiene (BD), Acrylonitrile (AN) and Liquefied Natural Gas (LNG) as well as providing the related integrated logistics services to complement the existing businesses of Hong Seng Group. The incorporation of HS Petchem is not expected to have any immediate material effect on the earnings or net assets of Hong Seng Group. None of the directors, major shareholders of Hong Seng and/or persons connected with them have any interest, whether direct or indirect, in the incorporation of HS Petchem, save except through Hong Seng. This announcement is dated 22 October 2020.

icy97

Notice of Person Ceasing (Section 139 of CA 2016)

HONG SENG CONSOLIDATED BERHAD

Particulars of Substantial Securities Holder

Name	HONG SENG ASSEMBLY SDN. BHD.
Address	7137, Sg. Puyu Butterworth 13020 Pulau Pinang Malaysia.
Company No.	199701000406 (415902-P)
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	Ordinary shares
Name of registered holder	GRANDSTEAD SDN BHD PLEDGED SECURITIES ACCOUNT FOR HONG SENG ASSEMBLY SDN BHD
Address of registered holder	Unit C-01-1, Block C, Plaza GlomacNo. 6, Jalan SS7/19, Kelana Jaya47301 Petaling Jaya, Selangor
Date of cessation	28 Oct 2020

No of securities disposed	136,508,200
Circumstances by reason of which a person ceases to be a substantial shareholder	Disposal of shares via Direct Business Transaction
Nature of interest	Direct Interest
Date of notice	28 Oct 2020
Date notice received by Listed Issuer	28 Oct 2020

Notice of Interest Sub. S-hldr (Section 137 of CA 2016)

HONG SENG CONSOLIDATED BERHAD

Particulars of Substantial Securities Holder

Name	HONG SENG FRONTIER SDN. BHD. (FORMERLY KNOWN AS HS FRONTIER SDN. BHD.)
Address	7137, Sg. Puyu Butterworth 13020 Pulau Pinang Malaysia.
Company No.	201601028748 (1199687-P)
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	Ordinary shares
Name of registered holder	GRANDSTEAD SDN BHD PLEDGED SECURITIES ACCOUNT FOR HONG SENG FRONTIER SDN BHD
Address of registered holder	Unit C-01-1, Block C, Plaza GlomacNo. 6, Jalan SS7/19, Kelana Jaya47301 Petaling Jaya, Selangor

Date interest acquired & no of securities acquired
Date interest acquired	28 Oct 2020
No of securities	136,508,200
Circumstances by reason of which Securities Holder has interest	Acquisition of shares via Direct Business Transaction
Nature of interest	Direct Interest
Total no of securities after change
Direct (units)	136,508,200
Direct (%)	26.324
Indirect/deemed interest (units)
Indirect/deemed interest (%)
Date of notice	28 Oct 2020
Date notice received by Listed Issuer	28 Oct 2020

Name	HONG SENG FRONTIER SDN. BHD. (FORMERLY KNOWN AS HS FRONTIER SDN. BHD.)
Address	7137, Sg. Puyu Butterworth 13020 Pulau Pinang Malaysia.
Company No.	201601028748 (1199687-P)
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	Ordinary shares

Details of changes

No	Date of change	No of securities	Type of Transaction	Nature of Interest
1	03 Nov 2020	136,508,200	Transferred	Direct Interest
	Name of registered holder	GRANDSTEAD SDN BHD PLEDGED SECURITIES ACCOUNT FOR HONG SENG FRONTIER SDN BHD
	Address of registered holder	Unit C-01-1, Block C, Plaza Glomac No. 6, Jalan SS7/19, Kelana Jaya 47301 Petaling Jaya, Selangor
	Description of "Others" Type of Transaction
2	03 Nov 2020	111,508,200	Transferred	Direct Interest
	Name of registered holder	KENANGA NOMINEES (TEMPATAN) SDN BHD PLEDGED SECURITIES ACCOUNT FOR HONG SENG FRONTIER SDN BHD
	Address of registered holder	Level 15, Kenanga Tower No. 237, Jalan Tun Razak 50400 Kuala Lumpur
	Description of "Others" Type of Transaction
3	03 Nov 2020	25,000,000	Transferred	Direct Interest
	Name of registered holder	HONG SENG FRONTIER SDN BHD
	Address of registered holder	7137, Sg. Puyu 13020 Butterworth
	Description of "Others" Type of Transaction
4	03 Nov 2020	24,500,000	Disposed	Direct Interest
	Name of registered holder	HONG SENG FRONTIER SDN BHD
	Address of registered holder	7137, Sg. Puyu 13020 Butterworth
	Description of "Others" Type of Transaction

Circumstances by reason of which change has occurred	Transfer of shares / Disposal of shares via Direct Business Transaction
Nature of interest	Direct Interest
Direct (units)	112,008,200
Direct (%)	21.583
Indirect/deemed interest (units)
Indirect/deemed interest (%)
Total no of securities after change	112,008,200
Date of notice	04 Nov 2020
Date notice received by Listed Issuer	04 Nov 2020

icy97

Type	Announcement
Subject	MEMORANDUM OF UNDERSTANDING
Description	MEMORANDUM OF UNDERSTANDING WITH SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD
The Board of Directors of Hong Seng Consolidated Berhad (formerly known as MSCM Holdings Berhad) wishes to announce its wholly-owned subsidiary company, namely, HS Bio Supplies Sdn. Bhd. (formerly known as HC MSC Sdn. Bhd.) ("HS Bio") has on 4 November 2020 entered into a Memorandum of Understanding (“MOU”) with Shijiazhuang Yiling Pharmaceutical Co., Ltd ("Yiling Pharmaceutical") for Yiling Pharmaceutical to authorise HS Bio to act as their agent in Malaysia to obtain the relevant approvals for their therapeutic and health related products from Malaysia's Ministry of Health on behalf of Yiling Pharmaceutical. Details of the announcement are set out in the file attached. This announcement is dated 4 November 2020.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3102594

Attachments Hong Seng-Anouncement (MOU-Yiling Pharmaceutical).pdf

Type	Announcement
Subject	MEMORANDUM OF UNDERSTANDING
Description	MEMORANDUM OF UNDERSTANDING WITH BEIJING APPLIED BIOLOGICAL TECHNOLOGIES CO., LTD
The Board of Directors of Hong Seng Consolidated Berhad (formerly known as MSCM Holdings Berhad) wishes to announce its wholly-owned subsidiary company, namely, HS Bio Supplies Sdn. Bhd. (formerly known as HC MSC Sdn. Bhd.) ("HS Bio") has on 4 November 2020 entered into a Memorandum of Understanding (“MOU”) with Beijing Applied Biological Technologies Co., Ltd to jointly work together for development of the technologies, products, services and total solutions related to the 2019-nCoV PCR test kit and other infrastructure development projects within the scope of cooperation as entailed in the MOU. Details of the announcement are set out in the file attached. This announcement is dated 4 November 2020.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3102579

Attachments Hong Seng-Anouncement (MOU)-Beijing Applied Biological.pdf

SUMMARY OF KEY FINANCIAL INFORMATION 30 Sep 2020

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Sep 2020	30 Sep 2019	30 Sep 2020	30 Sep 2019
		$$'000	$$'000	$$'000	$$'000

1	Revenue	530	1,323	1,058	3,344
2	Profit/(loss) before tax	1,429	951	1,428	1,363
3	Profit/(loss) for the period	1,429	943	1,428	1,355
4	Profit/(loss) attributable to ordinary equity holders of the parent	1,429	943	1,428	1,355
5	Basic earnings/(loss) per share (Subunit)	0.33	0.36	0.38	0.51
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.2142		0.1925

Notice of Person Ceasing (Section 139 of CA 2016)

HONG SENG CONSOLIDATED BERHAD

Particulars of Substantial Securities Holder

Name	MASTER KNOWLEDGE SDN. BHD.
Address	No. 9A, Jalan Medan Tuanku Medan Tuanku Kuala Lumpur 50300 Wilayah Persekutuan Malaysia.
Company No.	201101009262 (937401-M)
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	Ordinary shares
Name of registered holder	Kenanga Nominees (Tempatan) Sdn Bhd Pledged Securities Account for Master Knowledge Sdn Bhd
Address of registered holder	Level 15, Kenanga Tower, 237 Jalan Tun Razak50400 Kuala Lumpur
Date of cessation	27 Nov 2020

No of securities disposed	34,803,600
Circumstances by reason of which a person ceases to be a substantial shareholder	Disposal of shares via direct business transaction / Disposal of shares via open market
Nature of interest	Direct Interest
Date of notice	30 Nov 2020
Date notice received by Listed Issuer	30 Nov 2020

Name	RADIANCE DYNASTY SDN. BHD.
Address	No. 14, Jalan PE 11 Taman Paya Emas Paya Rumput 76450 Melaka Malaysia.
Company No.	201901018642 (1327971-U)
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	Ordinary Shares

Details of changes

No	Date of change	No of securities	Type of Transaction	Nature of Interest
1	27 Nov 2020	30,115,700	Acquired	Direct Interest
	Name of registered holder	Valhalla Capital Sdn. Bhd. Pledged Securities Account for Radiance Dynasty Sdn. Bhd.
	Address of registered holder	PS-M-01, Wisma PJ5 Soho, No. 4B, Jalan SS5D/6 Kelana Jaya, 47301 Petaling Jaya Selangor Darul Ehsan
	Description of "Others" Type of Transaction

Circumstances by reason of which change has occurred	Acquisition of shares via Direct Business Transaction.
Nature of interest	Direct Interest
Direct (units)	70,425,000
Direct (%)	13.57
Indirect/deemed interest (units)
Indirect/deemed interest (%)
Total no of securities after change	70,425,000
Date of notice	30 Nov 2020
Date notice received by Listed Issuer	30 Nov 2020

Notice of Person Ceasing (Section 139 of CA 2016)

HONG SENG CONSOLIDATED BERHAD

Particulars of Substantial Securities Holder

Name	YONG MONG HUAY
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	Ordinary shares
Name of registered holder	Grandstead Sdn Bhd Pledged Securities Account For Yong Mong Huay
Date of cessation	24 Dec 2020

No of securities disposed	10,000,000
Circumstances by reason of which a person ceases to be a substantial shareholder	Disposal of shares via Direct Business Transaction
Nature of interest	Direct Interest
Date of notice	24 Dec 2020
Date notice received by Listed Issuer	24 Dec 2020

Type	Announcement
Subject	OTHERS
Description	HONG SENG CONSOLIDATED BERHAD (FORMERLY KNOWN AS MSCM HOLDINGS BERHAD) ("HONG SENG" OR THE "COMPANY") AND ITS SUBSIDIARIES ("HONG SENG GROUP" OR THE "GROUP") - ACCEPTANCE OF LETTER FOR INTEREST TO ACQUIRE LAND
The Board of Directors of Hong Seng wishes to announce that Hong Seng Industries Sdn Bhd (Registration No. 202001039503 (1395824-P)) (a wholly-owned subsidiary of the Company) has on 28 December 2020 issued a letter of acceptance to accept a Letter issued by Northern Corridor Implementation Authority in relation to its interest to acquire a federal land in Kedah Rubber City. Details of the announcement are set out in the file attached. This announcement is dated 28 December 2020.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3116835

Attachments Hong Seng-Anouncement (Proposed Land Acquisition).pdf

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	ACQUISITION OF 32% EQUITY INTEREST IN EMEDASIA SDN BHD BY HS BIO SUPPLIES SDN BHD (FORMERLY KNOWN AS HC MSC SDN BHD), A WHOLLY-OWNED SUBSIDIARY OF THE COMPANY
The Board of Directors of Hong Seng Consolidated Berhad (formerly known as MSCM Holdings Berhad) ("Company" or "Hong Seng") wishes to announce that HS Bio Supplies Sdn Bhd (formerly known as HC MSC Sdn Bhd), a wholly-owned subsidiary of the Company, had on 31 December 2020 entered into a Conditional Shares Sale Agreement with Open Dynamics Sdn Bhd ("Vendor") for the acquisition of 32% of the equity interest in eMedAsia Sdn Bhd ("eMedAsia"), comprising 4,000 ordinary shares in eMedAsia for a purchase consideration of RM3,000,000.00 to be fully satisfied via the issuance of 3,000,000 new ordinary shares by Hong Seng to the Vendor ("Consideration Shares") at an issue price of RM1.00 per Consideration Share. Details of the announcement are set out in the file attached. This announcement is dated 31 December 2020.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3117906

Attachments Hong Seng-Announcement-Porposed Acquisition (eMedAsia) 31.12.2020.pdf

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	ACQUISITION OF 60% EQUITY INTEREST IN NEOGENIX LABORATOIRE SDN BHD BY HS BIO SUPPLIES SDN BHD (FORMERLY KNOWN AS HC MSC SDN BHD), A WHOLLY-OWNED SUBSIDIARY OF THE COMPANY
The Board of Directors of Hong Seng Consolidated Berhad (formerly known as MSCM Holdings Berhad) ("Company") wishes to announce that HS Bio Supplies Sdn Bhd (formerly known as HC MSC Sdn Bhd), a wholly-owned subsidiary of the Company, had on 31 December 2020 entered into a Shares Sale Agreement with Neoh Cheu An for the acquisition of 60% of the equity interest in Neogenix Laboratoire Sdn Bhd ("Neogenix"), comprising 120,000 ordinary shares in Neogenix for a cash consideration of RM6,500,000.00 only. Details of the announcement are set out in the file attached. This announcement is dated 31 December 2020.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3117905

Attachments Hong Seng-Announcement-Proposed Acquisition (Neogenix) 31.12.2020.pdf

HONG SENG CONSOLIDATED BERHAD

Type	Reply to Query
Reply to Bursa Malaysia's Query Letter - Reference ID	IQL-05012021-00002
Subject	Acquisition of 60% equity interest in Neogenix Laboratoire Sdn Bhd by Hs Bio Supplies Sdn Bhd (formerly known as HC MSC Sdn Bhd), a wholly-owned subsidiary of the Company (Proposed Acquisition)
Description	REPLY TO THE QUERY FROM BURSA MALAYSIA SECURITIES BERHAD ("BURSA SECURITIES")HONG SENG CONSOLIDATED BERHAD (FORMERLY KNOWN AS MSCM HOLDINGS BERHAD) ("HONG SENG" OR THE "COMPANY") AND ITS SUBSIDIARIES ("HONG SENG GROUP" OR THE "GROUP") - PROPOSED ACQUISITION OF 60% EQUITY INTEREST IN NEOGENIX LABORATOIRE SDN BHD
Query Letter Contents	We refer to your Company’s announcement dated 31 December 2020 in respect of the aforesaid matter. In this connection, kindly furnish Bursa Securities with the following additional information for public release:- The  breakdown of sources of funds to Hong Seng Consolidated Berhad  for the Proposed Acquisition between internally generated funds and proceeds received from the conversion of irredeemable convertible preference shares.
We refer to the Company's announcement made on 31 December 2020 (“Announcement”) and the query from Bursa Securities dated 5 January 2021 ("Query") in relation to the Proposed Acquisition of Neogenix. Unless otherwise stated, defined terms used in this reply shall carry the same meanings as defined in the Announcement. The Company wishes to provide the following additional information pursuant to the Query. 1. The breakdown of sources of funds to Hong Seng Consolidated Berhad for the Proposed Acquisition between internally generated funds and proceeds received from the conversion of irredeemable convertible preference shares. Reply The Company intends to fund the Purchase Consideration of RM6,500,000 for the Proposed Acquisition as below: i) RM500,000 through internally generated fund; and ii) RM6,000,000 through proceeds received from the conversion of irredeemable convertible preference shares.

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	HONG SENG CONSOLIDATED BERHAD (FORMERLY KNOWN AS MSCM HOLDINGS BERHAD) ("HONG SENG" OR THE "COMPANY") AND ITS SUBSIDIARIES ("HONG SENG GROUP" OR THE "GROUP") - PROPOSED ACQUISITION OF 60% EQUITY INTEREST IN NEOGENIX LABORATOIRE SDN BHD
We refer to the Company's announcements made on 31 December 2020 and 6 January 2021 (“Announcements”) in relation to the Proposed Acquisition of Neogenix. Unless otherwise stated, defined terms used in this announcement shall carry the same meanings as defined in the Announcements. The Company wishes to announce that the Proposed Acquisition of Neogenix has been completed today in accordance with the terms and conditions as stated in the SSA. In consequence thereof, Neogenix has become a 60% owned subsidiary of the Company on even date. Furthermore, the Company would also like to provide an update on the Proposed Acquisition of Neogenix that Neogenix has recently, during the period pending Completion, further obtained a Letter of Award from Malaysia’s Ministry of Health to be one of the private laboratories to provide real-time PCR Covid-19 samples testing. This is expected to contribute positively to the overall future earnings of the Group. This announcement is dated 15 January 2021.

Type	Announcement
Subject	OTHERS
Description	INSTRUCTION LETTER TO START SUPPLY/SERVICE/WORK IN RELATION TO THE SUPPLY OF PCR TEST KITS FOR COVID-19 BETWEEN THE GOVERNMENT OF MALAYSIA AND PANTASNIAGA SDN. BHD., A 51% OWNED SUBSIDIARY OF HS BIO SUPPLIES SDN. BHD., WHICH IN TURN A WHOLLY-OWNED SUBSIDIARY OF HONG SENG CONSOLIDATED BERHAD ("HONG SENG" OR "COMPANY")
The Board of Directors of Hong Seng wishes to announce that the Pantasniaga Sdn. Bhd. (an Authorised Representative and Distributor for BGI Genomics Co., Ltd), a 51% owned subsidiary of HS Bio Supplies Sdn Bhd (formerly known as HC MSC Sdn Bhd), which in turn a wholly-owned subsidiary of the Company has on 3 February 2021 received a “Surat Arahan Memulakan Bekalan/Perkhidmatan/Kerja” i.e. an instruction letter to start supply/service/work (“Instruction Letter”) from the Government of Malaysia represented by the Ministry of Health of Malaysia to supply polymerase chain reaction (“PCR”) test kits for COVID-19 to the Institute for Medical Research (IMR), Ministry of Health Malaysia, for a total estimated sum of RM34.25 million in accordance with the terms and conditions stipulated in the Instruction Letter and subject to price negotiation between the Company and the Government of Malaysia (“Contract”). Details of the announcement are set out in the file attached. This announcement is dated 3 February 2021.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3126549

Attachments Hong Seng Announcement-Award from Gov of Malaysia (final).pdf

HONG SENG CONSOLIDATED BERHAD (FORMERLY KNOWN AS MSCM HOLDINGS BERHAD) ("HONG SENG" OR THE "COMPANY")PROPOSED SHARE SPLIT INVOLVING THE SUBDIVISION OF EVERY 1 EXISTING ORDINARY SHARE IN HONG SENG ("HONG SENG SHARE" OR THE "SHARE") HELD ON AN ENTITLEMENT DATE TO BE DETERMINED LATER INTO 2 HONG SENG SHARES ("PROPOSED SHARE SPLIT")https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3126819

icy97

Type	Announcement
Subject	OTHERS
Description	HONG SENG CONSOLIDATED BERHAD (FORMERLY KNOWN AS MSCM HOLDINGS BERHAD) ("HONG SENG" OR THE "COMPANY") AND ITS SUBSIDIARIES ("HONG SENG GROUP" OR THE "GROUP") - HEADS OF AGREEMENT
The Board of Directors of Hong Seng wishes to announce that HS Bio Sdn Bhd (formerly known as HS Bio Supplies Sdn Bhd), a wholly-owned subsidiary of the Company has on 23 July 2021 entered into a Heads of Agreement with Dato’ Seri Shahril Bin Mokhtar, Datuk Wan Khalik Bin Wan Muhammad and RZAC Business Sdn Bhd in relation to the proposed acquisition of 510,000 ordinary shares in RZAC Immunesafe Sdn Bhd (“RZAC”), representing 51% of the equity interest in RZAC for a total proposed purchase consideration of RM40.30 million. Details of the announcement are set out in the file attached. This announcement is dated 23 July 2021.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3177421

Attachments Hong Seng - Announcement (HOA-RZAC)-Final.pdf

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	HONG SENG CONSOLIDATED BERHAD (FORMERLY KNOWN AS MSCM HOLDINGS BERHAD) ("HONG SENG" OR THE "COMPANY") AND ITS SUBSIDIARIES ("HONG SENG GROUP" OR THE "GROUP") - SHARES SALE AGREEMENT
On 23 July 2021, the Company’s wholly-owned subsidiary HS Bio Sdn Bhd (formerly known as HS Bio Supplies Sdn Bhd) (“HS Bio” or “Purchaser”) had entered into a Heads of Agreement (“HOA”) with Dato’ Seri Shahril Bin Mokhtar, Datuk Wan Khalik Bin Wan Muhammad and RZAC Business Sdn Bhd (collectively referred to as the “Vendors”) in relation to the proposed acquisition of 510,000 ordinary shares in RZAC Immunesafe Sdn Bhd (“RZAC”), representing 51% of the equity interest in RZAC. Pursuant to the HOA, the Board of Directors of Hong Seng wishes to announce that HS Bio has on 1 October 2021 entered into a Shares Sale Agreement with the Vendors, to undertake the proposed acquisition of 510,000 ordinary shares in RZAC (“Sale Shares”), representing 51% of the equity interest in RZAC, from the Vendors for a total purchase consideration of RM20 million to be satisfied via a combination of cash payment of RM2 million and issuance of 37,800 new ordinary shares in HS Bio at an issue price of approximately RM476 each. Separately, HS Bio has also on 1 October 2021 entered into a Shareholders’ Agreement with the Vendors to set forth all their rights and obligations between each other as well as to define and regulate their relationship in respect to the organisation, management and operations of RZAC. Details of the announcement are set out in the file attached. This announcement is dated 1 October 2021.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3197572

Attachments Hong Seng - Announcement for Proposed Acquisition of RZAC-Final.pdf

icy97

Type	Reply to Query
Reply to Bursa Malaysia's Query Letter - Reference ID	IQL-04102021-00001
Subject	Proposed acquisition of 510,000 ordinary shares in RZAC Immunesafe Sdn Bhd (RZAC) (Sale Shares), representing 51% of the equity interest in RZAC, from Dato Seri Shahril Bin Mokhtar, Datuk Wan Khalik Bin Wan Muhammad and RZAC Business Sdn Bhd (Vendors) for a total purchase consideration of RM20 million to be satisfied via a combination of cash payment of RM2 million and issuance of 37,800 new ordinary shares in HS Bio Sdn Bhd (HS Bio) at an issue price of approximately RM476 each
Description	REPLY TO THE QUERY FROM BURSA MALAYSIA SECURITIES BERHAD ("BURSA SECURITIES")HONG SENG CONSOLIDATED BERHAD (FORMERLY KNOWN AS MSCM HOLDINGS BERHAD) ("HONG SENG" OR THE "COMPANY") AND ITS SUBSIDIARIES ("HONG SENG GROUP" OR THE "GROUP") - SHARES SALE AGREEMENT FOR THE PROPOSED ACQUISITION OF 51% EQUITY INTEREST IN RZAC IMMUNESAFE SDN BHD
Query Letter Contents	We refer to your Company’s announcement dated 1 October 2021, in respect of the aforesaid matter. In this connection, kindly furnish Bursa Securities with the following additional information for public release:- Details of the Profit Guarantee provided by the Vendors and HS Bio’s right of recourse in the event the Profit Guarantee is not met. Basis and assumptions of RZAC’s expected profit after taxation of not less than RM40 million within a period of 12 months from 1 October 2021. The date of valuation by Crowe Advisory Sdn Bhd on the Sale Shares. Names of RZAC Business Sdn Bhd’s directors and substantial shareholders together with their respective direct and indirect shareholdings.
We refer to the Company's announcement made on 1 October 2021 (“Announcement”) and the query from Bursa Securities dated 4 October 2021 ("Query") in relation to the Proposed Acquisition of RZAC. Unless otherwise stated, defined terms used in this reply shall carry the same meanings as defined in the Announcement. The Company wishes to provide the following additional information pursuant to the Query. 1. Details of the Profit Guarantee provided by the Vendors and HS Bio’s right of recourse in the event the Profit Guarantee is not met. Reply As disclosed in Section 2.3.3 (ii) of the Announcement, the Vendors guaranteeing that RZAC shall attain and achieve the sales of 1 million units of Immusafe COVID+ Biochip and a guaranteed profit after taxation of RM40 million within 12 months from 1 October 2021 (“Profit Guarantee”). In the event the Vendors fail to achieve the Profit Guarantee, HS Bio shall be entitled to reduce the Consideration and consequently the number and value of the Consideration Shares to be allotted and issued and the reduction of the same shall be based on and in proportionate to, amongst others, the actual profit after tax achieved by RZAC calculated up to 30 September 2022. For the avoidance of doubt, in the event the Consideration has been reduced in accordance with this clause, the Cash Consideration must be deducted first from the reduced Consideration and thereafter, the balance Consideration Shares shall be allotted and issued accordingly. For information purpose, HS Bio’s 51% entitlement from the Profit Guarantee is approximately RM20.40 million. 2. Basis and assumptions of RZAC’s expected profit after taxation of not less than RM40 million within a period of 12 months from 1 October 2021. Reply As disclosed in Section 2.5 (i) (b) of the Announcement, RZAC has secured orders and commitments from its customers and it expects to supply 1 million units of the Immusafe COVID+ Biochip test kits to its customers which could generating an estimated revenue of up to RM250 million within a period of 12 months from 1 October 2021. In view of this, RZAC is expected to generate a profit after taxation of not less than RM40 million within a period of 12 months from 1 October 2021 from the said sales. 3. The date of valuation by Crowe Advisory Sdn Bhd (“Crowe”) on the Sale Shares. Reply The date of valuation on the Sale Shares by Crowe was as at 30 June 2021 based on the report issued by Crowe on 27 September 2021. 4. Names of RZAC Business Sdn Bhd’s directors and substantial shareholders together with their respective direct and indirect shareholdings. Reply As disclosed in Section 2.2 of the Announcement, the directors and shareholders of RZAC Business Sdn Bhd are Dato’ Sri Rayyan Joseph King (with 26% stake in the company) and Tengku Zawyah Binti Tengu Izham (with 74% stake in the company) as set out below: Name of directors & shareholders No. of shares % Dato’ Sri Rayyan Joseph King 195,000 26 Tengku Zawyah Binti Tengu Izham 555,000 74 Total 750,000 100 Their respective direct and indirect shareholdings in RZAC are as follows: Direct Indirect Shareholders No. of shares % No. of shares % Dato’ Sri Rayyan Joseph King - - 200,000 20 Tengku Zawyah Binti Tengu Izham

icy97

Type	Announcement
Subject	OTHERS
Description	HONG SENG CONSOLIDATED BERHAD (FORMERLY KNOWN AS MSCM HOLDINGS BERHAD) ("HONG SENG" OR THE "COMPANY") AND ITS SUBSIDIARIES ("HONG SENG GROUP" OR THE "GROUP") - HEADS OF AGREEMENT
The Board of Directors of Hong Seng wishes to announce that HS Bio Sdn Bhd (formerly known as HS Bio Supplies Sdn Bhd), a wholly-owned subsidiary of the Company has on 8 October 2021 entered into a Heads of Agreement with Russell Walter Boyd in relation to the proposed acquisition of 510,000 ordinary shares in Pow Pocket Sdn Bhd ("Pow Pocket"), representing 51% of the equity interest in Pow Pocket for a total proposed purchase consideration of RM200 million. Details of the announcement are set out in the file attached. This announcement is dated 8 October 2021.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3199237

Attachments Hong Seng - Announcement (HOA-Pow Pocket)-Final.pdf

icy97

HONG SENG CONSOLIDATED BERHAD

Instrument Category	Securities of PLC
Instrument Type	Warrants
Description	HONG SENG CONSOLIDATED BERHAD ("HONG SENG" OR THE "COMPANY")BONUS ISSUE OF 850,811,683 FREE WARRANTS ("WARRANTS B") ON THE BASIS OF 1 WARRANT B FOR EVERY 3 EXISTING ORDINARY SHARES IN HONG SENG ("HONG SENG SHARES") HELD BY THE ENTITLED SHAREHOLDERS OF HONG SENG AT 5.00 P.M. ON 1 OCTOBER 2021 ("BONUS ISSUE OF WARRANTS")

Listing Date	12 Oct 2021
Issue Date	04 Oct 2021
Issue/ Ask Price	Not Applicable
Issue Size Indicator	Unit
Issue Size in Unit	850,811,683
Maturity	Mandatory
Maturity Date	03 Oct 2024
Revised Maturity Date
Name of Guarantor	Not Applicable
Name of Trustee	Not Applicable
Coupon/Profit/Interest/Payment Rate	Not Applicable
Coupon/Profit/Interest/Payment Frequency	Not Applicable
Redemption	Not Applicable
Exercise/Conversion Period	3.00   Year(s)
Revised Exercise/Conversion Period	Not Applicable
Exercise/Strike/Conversion Price	Malaysian Ringgit (MYR)   2.6000
Revised Exercise/Strike/Conversion Price	Not Applicable
Exercise/Conversion Ratio	1:1
Revised Exercise/Conversion Ratio	Not Applicable
Mode of satisfaction of Exercise/ Conversion price	Cash
Settlement Type/ Convertible into	Physical (Shares)

icy97

Type	Reply to Query
Reply to Bursa Malaysia's Query Letter - Reference ID	IQL-12102021-00001
Subject	HEADS OF AGREEMENT (HOA)
Description	REPLY TO THE QUERY FROM BURSA MALAYSIA SECURITIES BERHAD ("BURSA SECURITIES")HONG SENG CONSOLIDATED BERHAD (FORMERLY KNOWN AS MSCM HOLDINGS BERHAD) ("HONG SENG" OR THE "COMPANY") AND ITS SUBSIDIARIES ("HONG SENG GROUP" OR THE "GROUP") - HEADS OF AGREEMENT FOR THE PROPOSED ACQUISITION OF 51% EQUITY INTEREST IN POW POCKET SDN BHD
Query Letter Contents	We refer to your Company’s announcement dated 8 October 2021, in respect of the aforesaid matter. In this connection, kindly furnish Bursa Securities with the following additional information for public release:- 1.       The consolidated net profits and net assets of Pow Pocket Sdn Bhd (“Pow Pocket”) based on its latest audited financial statements. 2.       The particulars of all liabilities, including contingent liabilities and guarantees to be assumed by HS Bio Sdn Bhd (“HSBio”)/Hong Seng Consolidated Berhad (“Hong Seng”) arising from the HOA. 3.       The expected launch date of Immunise. 4.       The basis of arriving at the purchase consideration for the Sale Shares of RM200 million, other than on a “willing buyer willing seller” basis. If it was based on net assets, the year the net assets were taken into consideration, quantifying the net assets and stating whether it was based on audited financial statements; 5.       A statement as to whether the profit guarantee of RM400 million of Pow Pocket is realistic. 6.       The details of HSBio’s right of recourse in the event the profit guarantee is not met. 7.       The prospects of Pow Pocket.
We refer to the Company's announcement made on 8 October 2021 (“Announcement”) and the query from Bursa Securities dated 12 October 2021 ("Query") in relation to the HOA for the Proposed Acquisition of Pow Pocket. Unless otherwise stated, defined terms used in this reply shall carry the same meanings as defined in the Announcement. Please refer to the attachment for additional information pursuant to the Query.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3200704

Attachments Hong Seng - Reply to Query (HOA-Pow Pocket)-Final.pdf

icy97

Type	Announcement
Subject	OTHERS
Description	HONG SENG CONSOLIDATED BERHAD ("HONG SENG" OR THE "COMPANY") AND ITS SUBSIDIARIES ("HONG SENG GROUP" OR THE "GROUP") - MASTER SERVICES AND LICENSE AGREEMENT
We refer to our announcements made on 16 February 2021 and 25 June 2021 in respect of a sublease of an industrial land measuring approximately 102.60 acres located at Kedah Rubber City (“KRC”) from Northern Corridor Implementation Authority for the purpose of building and operating a nitrile butadiene latex (“NBL”) manufacturing plant in KRC (“KRC NBL Project”) and announcement made on 9 February 2021 in respect of the Pre-Contract Agreement with PH2 Global Limited to conduct a feasibility study in relation to the KRC NBL Project. The feasibility study takes into consideration of the market demand, prospects of gloves and NBL market as well as profitability analysis for the operation of the NBL plant. After taking into consideration of the feasibility study and internal assessment, the Board had decided to undertake the KRC NBL Project. Further to the above, the Board of Directors of Hong Seng wishes to announce that Hong Seng Industries Sdn Bhd (a wholly-owned subsidiary of the Company) had on 1 November 2021 entered into a Master Services and License Agreement (“Agreement”) with Pacific Hemisphere Sdn Bhd (“PCF”) to engage PCF as a technology provider in relation to the KRC NBL Project subject to the terms and conditions as contained in the Agreement. Details of the announcement are set out in the file attached. This announcement is dated 1 November 2021.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3205776

Attachments Hong Seng-Announcement (MSLA with PCF)-Final.pdf

icy97

Type	Announcement
Subject	OTHERS
Description	HONG SENG CONSOLIDATED BERHAD ("HONG SENG" OR THE "COMPANY") AND ITS SUBSIDIARIES ("HONG SENG GROUP" OR THE "GROUP") - LETTER OF OFFER
The Board of Directors of Hong Seng wishes to announce that Hong Seng’s wholly owned subsidiary, HS Petchem Logistics Sdn Bhd had on 1 November 2021 accepted the Letter of Offer issued by Penang Port Sdn Bhd for the sub-lease of a part of an industrial land located at Prai Bulk Cargo Terminal, Pulau Pinang measuring 12,140 square meter in area for a period of 20 years for a total rental payment of RM8,529,564. Details of the announcement are set out in the file attached. This announcement is dated 1 November 2021.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3205794

Attachments Hong Seng-Announcement (Letter of Offer-PPSB)-Final.pdf

icy97

Type	Announcement
Subject	OTHERS
Description	Clarification on the news article published on Bernama Online, The Star Online, The Sun Daily Online and some other news platforms on 1 November 2021 entitled "Hong Seng Industries to invest RM3bln in worlds largest glove factory in Kedah".
Reference is made to the various erroneous headlines published by some media including Bernama Online, The Star Online, The Sun Daily Online and other news platforms on 1 November 2021 entitled “Hong Seng Industries to invest RM3bln in world’s largest glove factory in Kedah”:- In response to the above headlines, the Board of Directors of Hong Seng Consolidated Berhad (“Hong Seng” or “Company”) wishes to clarify that in respect of the Groundbreaking Ceremony held on 1 November 2021 as reported, Hong Seng Industries Sdn Bhd (a wholly-owned subsidiary of the Company) (“HS Industries”) is desirous of building and operating a nitrile butadiene latex (“NBL”) manufacturing plant with a planned capacity of 960 kilo-tonnes per annum (“ktpa”) (over 4 phases with 240 ktpa each phase) in Kedah Rubber City (“KRC NBL Project”) but not a glove manufacturing factory as stated in those articles. The KRC NBL Project is to produce NBL which is the synthetic latex required to manufacture nitrile gloves that Malaysia is currently the world's largest producer and supplier.   Please refer to the announcement made on 1 November 2021 in relation to a Master Services and License Agreement entered with Pacific Hemisphere Sdn Bhd (“PCF”) to engage PCF as a technology provider in relation to the KRC NBL Project for further details. In response, the Group has taken action to inform the respective publications and news platforms on the abovementioned error and most of the articles have been rectified accordingly. This announcement is dated 2 November 2021.

icy97

Type	Reply to Query
Reply to Bursa Malaysia's Query Letter - Reference ID	IQL-03112021-00001
Subject	LETTER OF OFFER MASTER SERVICES AND LICENSE AGREEMENT
Description	REPLY TO THE QUERY FROM BURSA MALAYSIA SECURITIES BERHAD ("BURSA SECURITIES")HONG SENG CONSOLIDATED BERHAD ("HONG SENG" OR THE "COMPANY") AND ITS SUBSIDIARIES ("HONG SENG GROUP" OR THE "GROUP")LETTER OF OFFER ("LOO")MASTER SERVICES AND LICENSE AGREEMENT ("MSLA")
Query Letter Contents	We refer to your Company’s announcements dated 1 November 2021, in respect of the aforesaid matters. In this connection, kindly furnish Bursa Securities with the following additional information for public release:- LETTER OF OFFER 1.       The expected date of commencement and completion of the construction of tank farm facilities and warehousing facilities. 2.       The estimated cost of construction. 3.       The sources of funding and its breakdown. MASTER SERVICES AND LICENSE AGREEMENT 1.       The expected date of commencement of production of nitrile butadiene latex (“NBL”) and the percentage of completion of the NBL factory.
We refer to our LOO announcement and MSLA announcement made on 1 November 2021 (“Announcements”) and query from Bursa Securities dated 3 November 2021 (“Query”) in relation to the Announcements. Unless otherwise defined, the definitions set out in this reply shall carry the same meanings as defined in the Announcements. Further to the Announcements, please refer to the attachment for additional information pursuant to the Query.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3207004

Attachments Hong Seng-Reply to query-LOO MSLA -Final.pdf

icy97

Type	Announcement
Subject	OTHERS
Description	Clarification on the news article published in The Edge on 8 November 2021 entitled Hong Seng Consolidateds ambitious projections
Reference is made to the following statement appeared in the article published in The Edge on 8 November 2021 entitled “Hong Seng Consolidated’s ambitious projections”. “Quite remarkably, Hong Seng is projecting an annual revenue of RM4.22 billion upon full completion of the plant, noting that on longer-term horizon, the total estimated revenue from 2024 to 2031 would amount to RM18 billion.” In response to the above statement, the Board of Directors of Hong Seng Consolidated Berhad (“Hong Seng” or “Company”) wishes to clarify that the projected annual revenue of RM4.22 billion mentioned is referring to the estimated annual revenue assuming at full production of the NBL plant with a total planned capacity of 960 ktpa (total of 4 phases with 240 ktpa each phase) based on 10 years historical average selling price of NBL prior to year 2019 of USD1,250 per wet metric ton (Source: PH2 Global Ltd). The projected annual revenue were derived based on internal assessment and were not reviewed by external auditors. The NBL plant is planned to commence in phases, with the Phase 1 production of NBL to commence in the second quarter of year 2024, Phase 2 commencing in the second quarter of year 2026, Phase 3 commencing in the second quarter of year 2028 and the expected full operations of all 4 phases by third quarter of year 2030. The Company estimates that the NBL plant will be operating in full capacity in the financial year ending (“FYE”) 30 September 2031. Thus, the total estimated revenue in aggregate based on the above planned phases from the FYE 30 September 2024 to the FYE 30 September 2031 is amounted to approximately RM18 billion. With the rising global demand as well as shortage of NBL supply, Hong Seng NBL supply is expected to fulfil to the market demand. In addition, the world major gloves producers are in Malaysia, hence Hong Seng is able to offer a competitive pricing for its NBL after taking into consideration of lower operational and logistic costs. Please refer to the announcement made on 1 November 2021 in relation to a Master Services and License Agreement entered with Pacific Hemisphere Sdn Bhd (“PCF”) to engage PCF as a technology provider in relation to the KRC NBL Project for further details (“Announcement”). Unless otherwise defined, the definitions set out in this reply shall carry the same meanings as defined in the Announcement. This announcement is dated 9 November 2021.

icy97

Type	Announcement
Subject	MEMORANDUM OF UNDERSTANDING
Description	HONG SENG CONSOLIDATED BERHAD ("HONG SENG" OR THE "COMPANY") AND ITS SUBSIDIARIES ("HONG SENG GROUP" OR THE "GROUP") - MEMORANDUM OF UNDERSTANDING WITH UNIVERSITI TUNKU ABDUL RAHMAN
The Board of Directors of Hong Seng wishes to announce that Neogenix Laboratoire Sdn Bhd (a 60% owned subsidiary of HS Bio Sdn Bhd (formerly known as HS Bio Supplies Sdn Bhd) and which in turn a wholly-owned subsidiary of Hong Seng), has via its 60% owned subsidiary, Neogenix Evo Sdn Bhd, on 10 November 2021 entered into a Memorandum of Understanding (“MOU”) with Universiti Tunku Abdul Rahman (“UTAR”) to explore areas for cooperation in relation to the UTAR Hospital Project subject to the terms and conditions of the MOU. Details of the announcement are set out in the file attached. This announcement is dated 10 November 2021.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3208176

Attachments Hong Seng - Announcement (MOU)-Final.pdf

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30 Sep 2021

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		Three Months	Three Months	Eighteen Months	Eighteen Months
		01 Jul 2021 To	01 Jul 2020 To	01 Apr 2020 To	01 Apr 2019 To
		30 Sep 2021	30 Sep 2020	30 Sep 2021	30 Sep 2020
		$$'000	$$'000	$$'000	$$'000

1	Revenue	56,464	530	146,969	0
2	Profit/(loss) before tax	45,727	1,429	69,848	0
3	Profit/(loss) for the period	39,970	1,429	58,870	0
4	Profit/(loss) attributable to ordinary equity holders of the parent	35,224	1,429	46,366	0
5	Basic earnings/(loss) per share (Subunit)	2.69	0.33	6.30	0.00
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.1930		0.1925

icy97

HONG SENG CONSOLIDATED BERHAD

Date of change	14 Dec 2021
Name	DATO' SERI DR CHEN CHAW MIN
Age	60
Gender	Male
Nationality	Malaysia
Designation	Non Executive Chairman
Directorate	Independent and Non Executive
Type of change	Resignation
Reason	To concentrate on his other carrers